APP and Alzheimer disease: We found AF102B to be an APP 5’UTR dependent translation activator that we propose represents an encouraging starting point for medicinal treatment of acute Pb and Mn toxicity to exposed brain neurons (i.e., in the younger population suffering from environmental/industrial heavy metal exposures long before the onset of an amyloidogenic cascade of AD).